OxyHelp
European-made hard-shell specialist. Premium build quality with polished stainless steel construction, pressure-sealed doors, and integrated exercise capability. Fills the gap between cheap Chinese hard-shells and $100K+ clinical units.
NOT CLEARED
No FDA clearance, registration, or CE marking found.
Key facts at a glance.
- Founded
- 2017
- Headquarters
- Europe (Romania-based manufacturing)
- Price range
- $10,000–$20,000
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $10,000 |
| 3-year total | $10,000 |
What the device does.
- + Specializes in hard-shell chambers (not soft-shell)
- + OxyLife I monoplace: 1.5 ATA; OxyLife 2ATA: up to 2.0 ATA
- + Multiplace models seat 2-5 people
- + Pressure-sealed door with anti-friction bearings
- + Dual over-pressure safety mechanisms with automatic depressurization
- + Can accommodate stationary bike for exercise during sessions
- + CE certified, made in Europe
- + 2-year warranty extendable to 3 years
The trade-offs.
- + **European-made hard-shell specialist** — Romania-based manufacturing with polished stainless-steel construction
- + Pressure-sealed doors + integrated exercise capability
- + Fills the $10K-20K gap between Chinese hard-shells (Macy-Pan, OxyRevo) and $100K+ clinical units
- + Premium build quality with European manufacturing standards
- − **Not FDA-cleared for US market** (CE-mark European-only)
- − $10K-20K pricing meaningfully above US-domestic FDA-cleared soft-shells
- − Limited US distribution / support (Europe-based brand)
- − Smaller catalog vs Macy-Pan / OxyRevo wider ranges
Home wellness users, spas, wellness centers, clinics wanting premium hard-shell chambers
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
OxyHelp is the European-made hard-shell hyperbaric specialist — founded 2017 with Romania-based manufacturing, structurally positioned to fill the $10K-20K gap between Chinese hard-shells (Macy-Pan, OxyRevo at $2,500-5,500) and $100K+ clinical units (Atlanta Hyperbaric). Polished stainless-steel construction + pressure-sealed doors + integrated exercise capability provide premium build quality with European manufacturing standards distinct from Chinese-direct alternatives.
The structural editorial caveats: not FDA-cleared for US market (CE-mark European-only — appropriate for EU buyers but US buyers should weight regulatory positioning), $10K-20K pricing is meaningfully above US-domestic FDA-cleared soft-shell alternatives (Newtowne $4,495, Summit to Sea $3,800-6,500), limited US distribution / support, and smaller catalog vs Chinese manufacturers’ wider ranges.
When OxyHelp Makes Sense
Strong fit: EU buyers wanting hard-shell quality with European manufacturing; mid-premium hard-shell tier ($10K-20K); polished aesthetic + integrated exercise capability priority.
Weaker fit: US-buyers wanting FDA-cleared positioning; cost-priority Chinese-direct (Macy-Pan, OxyRevo at half the price); soft-shell residential 1.3 ATA (Newtowne / Summit to Sea); clinical-tier $100K+ (Atlanta Hyperbaric).
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| OxyHelp entry hard-shell | ~$10K-15K |
| OxyHelp premium hard-shell | ~$15K-20K |
Compare: Macy-Pan ($2,500-5,000 China hard-shell), Henshaw UK (~$4K-25K hard-shell), Atlanta Hyperbaric ($15K-100K), Newtowne ($4,495 FDA-cleared soft-shell).
Verdict: Recommended
OxyHelp earns a recommended verdict on the strength of its European-made hard-shell positioning (Romania-based premium manufacturing), polished stainless-steel construction with pressure-sealed doors + integrated exercise capability, and structural pricing position filling the $10K-20K gap — balanced against not-FDA-cleared for US market (CE-mark European-only), premium pricing vs FDA-cleared US-domestic soft-shells, limited US distribution, and smaller catalog vs Chinese-manufacturer alternatives.
For EU buyers and US buyers willing to absorb non-FDA-cleared positioning for European hard-shell quality at $10K-20K, OxyHelp is structurally appropriate. For US-FDA-cleared positioning, cost-priority Chinese-direct, or soft-shell residential needs, alternatives are structurally better matched.
Changelog
- 2026-05-07: Initial review published based on OxyHelp published specifications, European manufacturing positioning, and pricing-tier documentation.
What we'll measure on the bench.
- Protocol
- Pressure gauge + dB-A meter + stopwatch
- Primary metric
- Max ATA pressure + pressurization time
- Pass threshold
- ±0.05 ATA of vendor claim · <70 dB-A
- Session shape
- 3 pressurization cycles + ambient dB at 6 ft
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.